Applications including "InertSustain AQ-C18"

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LC Technical Note InertSustain AQ-C18 InertSustain PFP
LT200 - InertSustain & Inertsil HPLC Columns for Reversed Phase Separation -

LC Technical Note InertSustain C18 InertSustain AQ-C18 InertSustainSwift C18 InertSustain AX-C18 Inertsil ODS-HL Inertsil ODS-4 Inertsil ODS-3 Inertsil ODS-P Inertsil ODS-EP InertSustain C8 Inertsil C8-4 Inertsil C4 Inertsil WP300 C18 Inertsil WP300 C8 Inertsil WP300 C4 InertSustain PFP InertSustain Phenyl InertSustain Phenylhexyl
LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -

LC Technical Note InertSustain AQ-C18
LC110 - Analysis of Quinic acid, Malic acid, Citric acid, Shikimic acid (Under the Condition of draft for USP, Aronia melanocarpa Fruit Aqueous Dry Extract, IDENTIFICATION C.HPLC PROFILE AND RATIO OF ORGANIC ACIDS) -

LC InertSearch InertSustain AQ-C18
LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -

LC InertSearch InertSustain AQ-C18
LC051 - Analysis of Vitamin C (Under the Condition of USP41-NF36, Vitamin C ASSAY,PROCEDURE 1) -

LC InertSearch InertSustain AQ-C18
LC047 - Analysis of Homocysteine -

LC InertSearch InertSustain AQ-C18
LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC InertSearch InertSustain AQ-C18
LC013 - Analysis of Bleomycin sulfate -

LC InertSearch InertSustain AQ-C18
LC004 - Analysis of Urea and Thiourea -

LC InertSearch InertSustain AQ-C18
LB984 - Analysis of Sumatriptan -

LC InertSearch InertSustain AQ-C18
LB980 - Analysis of Desloratadine -

LC InertSearch InertSustain AQ-C18
LB978 - Analysis of Hydrochlorothiazide -

LC InertSearch InertSustain AQ-C18
LB977 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain AQ-C18
LB967 - Analysis of Difluoroacetic acid and Trifluoroacetic acid -

LC InertSearch InertSustain AQ-C18
LB954 - Analysis of Difluoroacetic acid and Trifluoroacetic acid -

LC InertSearch InertSustain AQ-C18
LB947 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB946 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB945 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB935 - Analysis of Febuxostat -

LC InertSearch InertSustain AQ-C18
LB922 - Analysis of 4 Drugs -

LC InertSearch InertSustai AQ-C18 InertSustain AQ-C18
LB910 - Analysis of Fatty acids (C18-C26) -

LC InertSearch InertSustain AQ-C18
LB909 - Analysis of Fatty acids (C18-C26) -

LC InertSearch InertSustain AQ-C18
LB908 - Analysis of Fatty acids (C1-C18) -

LC InertSearch InertSustain AQ-C18
LB874 - Analysis of Captopril and Captopril Disulfide -

LC InertSearch InertSustain AQ-C18
LB873 - Tacrolimus Extended-Release Capsules -

LC InertSearch InertSustain AQ-C18
LB857 - Analysis of Natamycin (Analytical Method A) -

LC InertSearch InertSustain AQ-C18
LB854 - Analysis of Naringin and Hesperidin -

LC InertSearch InertSustain AQ-C18
LB851 - Analysis of Calcium Pantothenate -

LC InertSearch InertSustain AQ-C18
LB819 - Analysis of ATP and Cyclic nucleotide (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB814 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AQ-C18
LB813 - Analysis of Fosetyl and Glyphosate -

LC InertSearch InertSustain AQ-C18
LB809 - Analysis of ATP related compounds and Guanylic acid -

LC InertSearch InertSustain AQ-C18
LB709 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LC InertSearch InertSustain AQ-C18
LB708 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LC InertSearch InertSustain AQ-C18
LB707 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LC InertSearch InertSustain AQ-C18
LB706 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LC InertSearch InertSustain AQ-C18
LB705 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LC InertSearch InertSustain AQ-C18
LB696 - Analysis of Trifluoroacetic acid -

LC InertSearch InertSustain AQ-C18
LB692 - Analysis of Nitrosamines -

LC InertSearch InertSustain AQ-C18
LB689 - Analysis of Capsaicin in red pepper (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB656 - Analysis of Peptides -

LC InertSearch InertSustain AQ-C18
LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -

LC InertSearch InertSustain AQ-C18 HP
LB621 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) -

LC InertSearch InertSustain C18
LT161 - Purification of Ribavirin in Human Serum Using MonoSpin PBA -

LC Technical Note InertSustain AQ‐C18 HP
LT124 - Analysis of Furfural in Insulating Oil -

LC Technical Note InertSustainSwift C18 InertSustain AQ-C18
LT092 - Analysis of Tranexamic Acid According to the Japanese Pharmacopoeia -

LC Technical Note InertSustain AQ-C18 Inertsil ODS-4
LL027 - Analysis of Isothiazolinone preservatives -

LC InertSearch InertSustain AQ-C18
LB568 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Steviol Glycosides) -

LC InertSearch InertSustain AQ-C18
LB566 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Stevia Extract) -

LC InertSearch InertSustain AQ-C18
LB563 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -

LC InertSearch InertSustain AQ-C18
LB561 - Analysis of Neotame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -

LC InertSearch InertSustain AQ-C18
LB560 - Analysis of Advantame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -

LC InertSearch InertSustain AQ-C18
LB559 - Analysis of Artificial sweeteners -

LC InertSearch InertSustain AQ-C18
LB544 - Analysis of Catecholamines -

LC InertSearch InertSustain AQ-C18
LB522 - Analysis of Glutathione and its related compounds -

LC InertSearch InertSustain AQ-C18
LB507 - Analysis of Fatty acids by LC/MS/MS -

LC InertSearch InertSustain AQ-C18
LB485 - Analysis of Pyridoxal Phosphate Hydrate (Under the Condition of the Japanese Pharmacopoeia, (4) Related subatances) -

LC InertSearch InertSustain AQ-C18
LB455 - Analysis of Polar Peptides -

LC InertSearch InertSustain AQ-C18
LB452 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia, Tranexamic acid Tablets) -

LC InertSearch InertSustain AQ-C18
LB451 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain AQ-C18
LB450 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain AQ-C18
LB443 - Analysis of Nucleotide -

LC InertSearch InertSustain AQ-C18
LB441 - Analysis of Aflatoxin M1(InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB439 - Analysis of Myoglobin Digests (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB437 - Analysis of BSA Digests (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB435 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (6) 2-Pyrrolidone) -

LC InertSearch InertSustain AQ-C18
LB433 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (4) 1-Vinyl-2-pyrrolidone) -

LC InertSearch InertSustain AQ-C18
LB428 - Analysis of Zonisamide -

LC InertSearch InertSustain AQ-C18
LB427 - Analysis of Zonisamide -

LC InertSearch InertSustain AQ-C18
LB416 - Analysis of Vitamin K (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB406 - Analysis of Hippuric acid -

LC InertSearch InertSustain AQ-C18 HP
LB402 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB401 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB398 - Analysis of 9 Drugs (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB392 - Analysis of Methacrylic acid (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB387 - Analysis of 12 Drugs (InertSustain AQ-C18 HP) -

LC InertSearch InertSustain AQ-C18 HP
LB381 - Analysis of Angiotensin II receptor blockers (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB380 - Analysis of ATP related compounds -

LC InertSearch InertSustain AQ-C18
LB378 - Analysis of Hippuric Acids -

LC InertSearch InertSustain AQ-C18 HP
LB377 - Analysis of 13 kinds of Aldehydes (Directed by Pre-Column Method with DNPH) -

LC InertSearch InertSustain AQ-C18 HP
LB366 - Analysis of Nucleoside and Nucleic acid base (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB365 - Analysis of Nucleoside and Nucleic acid base (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB364 - Analysis of Water-soluble Vitamins -

LC InertSearch InertSustain AQ-C18
LB363 - Analysis of Organic acid -

LC InertSearch InertSustain AQ-C18
LB362 - Analysis of β-blocker -

LC InertSearch InertSustain AQ-C18
LB361 - Analysis of Furfral and 5-Hydroxymethylfurfral (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18

Applications including "InertSustain AQ-C18"

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LT200 - InertSustain & Inertsil HPLC Columns for Reversed Phase Separation -

LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -

LC110 - Analysis of Quinic acid, Malic acid, Citric acid, Shikimic acid (Under the Condition of draft for USP, Aronia melanocarpa Fruit Aqueous Dry Extract, IDENTIFICATION C.HPLC PROFILE AND RATIO OF ORGANIC ACIDS) -

LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -

LC051 - Analysis of Vitamin C (Under the Condition of USP41-NF36, Vitamin C ASSAY,PROCEDURE 1) -

LC047 - Analysis of Homocysteine -

LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC013 - Analysis of Bleomycin sulfate -

LC004 - Analysis of Urea and Thiourea -

LB984 - Analysis of Sumatriptan -

LB980 - Analysis of Desloratadine -

LB978 - Analysis of Hydrochlorothiazide -

LB977 - Analysis of Dapagliflozin propandiol -

LB967 - Analysis of Difluoroacetic acid and Trifluoroacetic acid -

LB954 - Analysis of Difluoroacetic acid and Trifluoroacetic acid -

LB947 - Analysis of Glacial Acetic Acid -

LB946 - Analysis of Glacial Acetic Acid -

LB945 - Analysis of Glacial Acetic Acid -

LB935 - Analysis of Febuxostat -

LB922 - Analysis of 4 Drugs -

LB910 - Analysis of Fatty acids (C18-C26) -

LB909 - Analysis of Fatty acids (C18-C26) -

LB908 - Analysis of Fatty acids (C1-C18) -

LB874 - Analysis of Captopril and Captopril Disulfide -

LB873 - Tacrolimus Extended-Release Capsules -

LB857 - Analysis of Natamycin (Analytical Method A) -

LB854 - Analysis of Naringin and Hesperidin -

LB851 - Analysis of Calcium Pantothenate -

LB819 - Analysis of ATP and Cyclic nucleotide (InertSustain AQ-C18) -

LB814 - Analysis of Coenzyme A (CoA) -

LB813 - Analysis of Fosetyl and Glyphosate -

LB809 - Analysis of ATP related compounds and Guanylic acid -

LB709 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LB708 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LB707 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LB706 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LB705 - Analysis of Per - and Polyfluoroalkyl Substances (PFAS) -

LB696 - Analysis of Trifluoroacetic acid -

LB692 - Analysis of Nitrosamines -

LB689 - Analysis of Capsaicin in red pepper (InertSustain AQ-C18) -

LB656 - Analysis of Peptides -

LB635 - Analysis of Levetiracetam (Under the Condition of draft for USP) -

LB621 - Analysis of Venlafaxine hydrochloride (Under the Condition of USP41-NF36, Venlafaxine Hydrochloride Extended-Release Capsules) -

LT161 - Purification of Ribavirin in Human Serum Using MonoSpin PBA -

LT124 - Analysis of Furfural in Insulating Oil -

LT092 - Analysis of Tranexamic Acid According to the Japanese Pharmacopoeia -

LL027 - Analysis of Isothiazolinone preservatives -

LB568 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Steviol Glycosides) -

LB566 - Analysis of Steviol glycosides (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives), Stevia Extract) -

LB563 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -

LB561 - Analysis of Neotame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -

LB560 - Analysis of Advantame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -

LB559 - Analysis of Artificial sweeteners -

LB544 - Analysis of Catecholamines -

LB522 - Analysis of Glutathione and its related compounds -

LB507 - Analysis of Fatty acids by LC/MS/MS -

LB485 - Analysis of Pyridoxal Phosphate Hydrate (Under the Condition of the Japanese Pharmacopoeia, (4) Related subatances) -

LB455 - Analysis of Polar Peptides -

LB452 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia, Tranexamic acid Tablets) -

LB451 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -

LB450 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -

LB443 - Analysis of Nucleotide -

LB441 - Analysis of Aflatoxin M1(InertSustain AQ-C18) -

LB439 - Analysis of Myoglobin Digests (InertSustain AQ-C18) -

LB437 - Analysis of BSA Digests (InertSustain AQ-C18) -

LB435 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (6) 2-Pyrrolidone) -

LB433 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (4) 1-Vinyl-2-pyrrolidone) -

LB428 - Analysis of Zonisamide -

LB427 - Analysis of Zonisamide -

LB416 - Analysis of Vitamin K (InertSustain AQ-C18) -

LB406 - Analysis of Hippuric acid -

LB402 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LB401 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LB398 - Analysis of 9 Drugs (InertSustain AQ-C18) -

LB392 - Analysis of Methacrylic acid (InertSustain AQ-C18) -

LB387 - Analysis of 12 Drugs (InertSustain AQ-C18 HP) -

LB381 - Analysis of Angiotensin II receptor blockers (InertSustain AQ-C18) -

LB380 - Analysis of ATP related compounds -